Bio
Tom is currently the CEO of eSS. From its inception in 2007 to 2014, Tom served as COO of Worldwide Clinical Trials (WCT), a full service CRO. In the 4th quarter of 2007 and 1st quarter of 2008, WCT closed five (5) CRO acquisitions aggregating $95 million in revenues. Over the next 6 years, Tom and his two partners grew WCT to $300 million in revenues. Prior to WCT, Tom was in senior management positions in seve ....
Education